CRT 2026

Round Table Discussion | Imaging the Aortic Valve

Moderator(s)

• DM

  David Messika-Zeitoun, MD

  Disclosure information not submitted.
• 

  Gaby Weissman, MD

  Chief Clinical Cardiology
  MedStar Washington Hospital Center & Medstar Georgetown University Hospital
  Washington, District of Columbia, United States

  Disclosure information not submitted.
• 

  Neil J. Weissman, MD

  Chief Scientific Officer
  MedStar Health
  Washington, District of Columbia, United States

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Ian C. Gilchrist, Sr., MD, MSCAI

  Professor of Interventional Cardiology
  Dartmouth Hitchcock Medical Center
  Moultonborough, New Hampshire, United States

  Disclosure(s): No financial relationships to disclose
• 

  Zvonimir Krajcer, MD

  PVD program director, Editor-in Chief-THI Journal
  Texas Heart Center for Cardiovascular Care at Texas Heart Institute
  Houston, Texas, United States

  Disclosure(s): Anaxiom Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Second Heart Assist, Inc.: Stock-privately held company (Ongoing); Taurus Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)
• 

  Fadi A. Matar, MD, FACC, FSCAI

  Professor of Medicine, Chief of Cardiology
  University of South Florida
  Tampa, Florida, United States

  Disclosure(s): No financial relationships to disclose
• 

  Diego Medvedofsky, MD

  Attending Cardiologist
  MedStar Heart and Vascular Institute, MedStar Cardiovascular Research Network at Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure information not submitted.
• 

  Stephanie Sellers, PhD

  Assistant Professor
  University of British Columbia
  Vancouver, British Columbia, Canada

  Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); BDC Labs: Grant/Research Support (Ongoing); Corcym: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Excision Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Stock Options [in privately held companies] (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Vivitro Labs: Grant/Research Support (Ongoing)
• 

  Dee Dee Wang, MD

  Section Head Cardiac Imaging
  NCH Rooney Heart Institute, Michigan, United States

  Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Zuyue Wang, MD

  In transition
  In transition
  Plano, Texas, United States

  Disclosure(s): No financial relationships to disclose